报价延迟最少15分钟:2026/05/19 01:55 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
16.57 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
35.34/222.67
|
|
企业价值
4,018.81B
|
| 资产负债 |
|
每股账面净值
15.58
|
| 现金流量 |
|
现金流量率
0.12
|
| 损益表 |
|
收益
1,508.93B
|
|
每股收益
8.80
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada. |
